Physician profile
Jocel Pagan-Ferrer
NPI 1508178104
$851.42
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $113 · 2021: $14.45 · 2022: $209 · 2023: $17.37 · 2024: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $313.16 | 2019-2022 | |
| Abbott Laboratories | $149.99 | 2024 | Merlin@Home |
| Teva Pharmaceuticals USA, INC. | $112.50 | 2020 | |
| Amgen INC. | $99.60 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $69.58 | 2024 | Eliquis |
| Merck Sharp & Dohme LLC | $49.19 | 2021-2023 | Zerbaxa, Recarbrio |
| Smith+Nephew, INC. | $24.71 | 2024 | Pico 7, Iodoflex Dressing 5x5g USA |
| Edwards Lifesciences Corporation | $19.18 | 2019 | |
| Chiesi USA, INC. | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jocel Pagan-Ferrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.